Insider Trading Alert - HCN, UNM And MRC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Aug. 20, 2014, 93 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $712.40 to $14,201,355.08.

Highlighted Stocks Traded by Insiders:

Health Care REIT (HCN) - FREE Research Report

Crabtree Michael A, who is Sr. Vice President & Treasurer at Health Care REIT, sold 1,000 shares at $65.90 on Aug. 20, 2014. Following this transaction, the Sr. Vice President & Treasurer owned 50,268 shares meaning that the stake was reduced by 1.95% with the 1,000-share transaction.

The shares most recently traded at $66.58, up $0.68, or 1.02% since the insider transaction. Historical insider transactions for Health Care REIT go as follows:

  • 4-Week # shares bought: 2,400
  • 4-Week # shares sold: 500
  • 12-Week # shares bought: 2,400
  • 12-Week # shares sold: 9,416
  • 24-Week # shares bought: 2,400
  • 24-Week # shares sold: 14,091

The average volume for Health Care REIT has been 2.3 million shares per day over the past 30 days. Health Care REIT has a market cap of $20.3 billion and is part of the financial sector and real estate industry. Shares are up 23.88% year-to-date as of the close of trading on Wednesday.

Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. The stock currently has a dividend yield of 4.83%. The company has a P/E ratio of 126.7. Currently, there are 6 analysts who rate Health Care REIT a buy, 2 analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCN - FREE

TheStreet Quant Ratings rates Health Care REIT as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, reasonable valuation levels, good cash flow from operations, increase in net income and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Health Care REIT Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Unum Group (UNM) - FREE Research Report

Goldsberry Ronald E, who is Director at Unum Group, sold 5,702 shares at $35.12 on Aug. 20, 2014. Following this transaction, the Director owned 16,494 shares meaning that the stake was reduced by 25.69% with the 5,702-share transaction.

The shares most recently traded at $35.20, up $0.08, or 0.23% since the insider transaction. Historical insider transactions for Unum Group go as follows:

  • 4-Week # shares sold: 61,090
  • 12-Week # shares sold: 115,112
  • 24-Week # shares sold: 194,780

The average volume for Unum Group has been 1.3 million shares per day over the past 30 days. Unum Group has a market cap of $8.9 billion and is part of the financial sector and insurance industry. Shares are up 0.26% year-to-date as of the close of trading on Wednesday.

Unum Group, together with its subsidiaries, provides group and individual disability insurance products in the United States and the United Kingdom. It operates in three segments: Unum US, Unum UK, and Colonial Life. The stock currently has a dividend yield of 1.88%. The company has a P/E ratio of 10.2. Currently, there are 4 analysts who rate Unum Group a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UNM - FREE

TheStreet Quant Ratings rates Unum Group as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Unum Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

MRC Global (MRC) - FREE Research Report

Braun James E, who is EVP and CFO at MRC Global, bought 1,000 shares at $24.60 on Aug. 20, 2014. Following this transaction, the EVP and CFO owned 35,878 shares meaning that the stake was boosted by 2.87% with the 1,000-share transaction.

The shares most recently traded at $24.96, up $0.36, or 1.46% since the insider transaction. Historical insider transactions for MRC Global go as follows:

  • 12-Week # shares bought: 9,000
  • 24-Week # shares bought: 9,000

The average volume for MRC Global has been 974,300 shares per day over the past 30 days. MRC Global has a market cap of $2.5 billion and is part of the basic materials sector and energy industry. Shares are down 22.75% year-to-date as of the close of trading on Wednesday.

MRC Global Inc. distributes pipes, valves, and fittings (PVF), and related products and services to the energy industry worldwide. The company has a P/E ratio of 20.6. Currently, there are 9 analysts who rate MRC Global a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MRC - FREE

TheStreet Quant Ratings rates MRC Global as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full MRC Global Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

Analysts' Actions -- Alaska Air, Canon, Greenlight Capital, Johnson Controls, Welltower and More

Analysts' Actions -- Alaska Air, Canon, Greenlight Capital, Johnson Controls, Welltower and More

REITs Will Be All Right Despite Rising Rates

REITs Will Be All Right Despite Rising Rates

Bullish and Bearish Reversals in the Market

Bullish and Bearish Reversals in the Market

Welltower Tops Fourth Quarter Estimates

Welltower Tops Fourth Quarter Estimates

Shakeups at 2 REITs Could Benefit Investors, but It May Take Time

Shakeups at 2 REITs Could Benefit Investors, but It May Take Time